1 | min | 22,795 |
2 | cmh₂o | 41 |
3 | min/session | 33 |
4 | ml/kg-1 | 16 |
5 | pmol/min | 14 |
6 | cigarettes/d | 8 |
7 | min-fa30 | 7 |
8 | min.day-1 | 7 |
9 | alpha-dihydrotestosterone | 6 |
10 | c.c | 5 |
11 | dbhl | 5 |
12 | dyn/cm² | 5 |
13 | ka/m | 5 |
14 | mg/day-placebo | 5 |
15 | mj/microbeam | 5 |
16 | wbcs/hpf | 5 |
17 | cm·h2o | 4 |
18 | g/hl | 4 |
19 | min/hour | 4 |
20 | alpha,6 | 3 |
21 | birds/replicate | 3 |
22 | calves/treatment | 3 |
23 | cfu/liter | 3 |
24 | degrees/second | 3 |
25 | mg® | 3 |
26 | ml.kg-1.h-1 | 3 |
27 | vrm | 3 |
28 | w.d | 3 |
29 | μg/strain | 3 |
30 | 1dneg | 2 |
31 | alpha-dihydroxypregn-4-en-3-one | 2 |
32 | alpha-hydroxy-5 | 2 |
33 | broilers/pen | 2 |
34 | clones/977 | 2 |
35 | cycles/h | 2 |
36 | g·d-1 | 2 |
37 | iu/cc | 2 |
38 | kcal/oz | 2 |
39 | mcg/min | 2 |
40 | min.the | 2 |
41 | min/time | 2 |
42 | monomethylation | 2 |
43 | mv-hz | 2 |
44 | nmol.l-1 | 2 |
45 | one-hour-sessions | 2 |
46 | packs-year | 2 |
47 | patients-group | 2 |
48 | pg/h | 2 |
49 | u/kg/week | 2 |
50 | µl/h | 2 |
51 | μmoll | 2 |
52 | 000+/-1000 | 1 |
53 | 80mg/d | 1 |
54 | 844.33 | 1 |
55 | 998±2655 | 1 |
56 | alpha-pregnanedione | 1 |
57 | bufogenins | 1 |
58 | carbonation/calcination | 1 |
59 | carcasses/treatment | 1 |
60 | cavh-hd | 1 |
61 | doctoral- | 1 |
62 | drops/minute | 1 |
63 | fish/tank | 1 |
64 | g-glucose | 1 |
65 | h-heating | 1 |
66 | inflations/min | 1 |
67 | kg/m2and | 1 |
68 | kgm/2 | 1 |
69 | kv/min | 1 |
70 | mcg/strain | 1 |
71 | mg/kg+placebo | 1 |
72 | mg/kg/6h | 1 |
73 | mgs/dl | 1 |
74 | mhz-1 | 1 |
75 | min-views | 1 |
76 | min/daily | 1 |
77 | min/view | 1 |
78 | miti-coded | 1 |
79 | mixed-locations | 1 |
80 | ml/kg/bw-1 | 1 |
81 | nmol.minute | 1 |
82 | non-can | 1 |
83 | non-neurosyphilitic | 1 |
84 | non-testers | 1 |
85 | non-transmitting | 1 |
86 | not-standardized | 1 |
87 | patients/48 | 1 |
88 | persons/group | 1 |
89 | pg/paw | 1 |
90 | pj/k | 1 |
91 | psgt | 1 |
92 | s/tooth | 1 |
93 | sapes | 1 |
94 | sec/day | 1 |
95 | segment-5 | 1 |
96 | squattings | 1 |
97 | stress-susceptible | 1 |
98 | symptomatic-lvef | 1 |
99 | thirst-minute | 1 |
100 | u/dl | 1 |
101 | ui/h | 1 |
102 | weeks+estramustine | 1 |
103 | £g/l | 1 |
104 | °c/open | 1 |
105 | μg/glycopyrronium | 1 |
106 | μg/injection | 1 |
1 | 000+/-1000 | 1 |
2 | 1dneg | 2 |
3 | 80mg/d | 1 |
4 | 844.33 | 1 |
5 | 998±2655 | 1 |
6 | alpha,6 | 3 |
7 | alpha-dihydrotestosterone | 6 |
8 | alpha-dihydroxypregn-4-en-3-one | 2 |
9 | alpha-hydroxy-5 | 2 |
10 | alpha-pregnanedione | 1 |
11 | birds/replicate | 3 |
12 | broilers/pen | 2 |
13 | bufogenins | 1 |
14 | c.c | 5 |
15 | calves/treatment | 3 |
16 | carbonation/calcination | 1 |
17 | carcasses/treatment | 1 |
18 | cavh-hd | 1 |
19 | cfu/liter | 3 |
20 | cigarettes/d | 8 |
21 | clones/977 | 2 |
22 | cmh₂o | 41 |
23 | cm·h2o | 4 |
24 | cycles/h | 2 |
25 | dbhl | 5 |
26 | degrees/second | 3 |
27 | doctoral- | 1 |
28 | drops/minute | 1 |
29 | dyn/cm² | 5 |
30 | fish/tank | 1 |
31 | g-glucose | 1 |
32 | g/hl | 4 |
33 | g·d-1 | 2 |
34 | h-heating | 1 |
35 | inflations/min | 1 |
36 | iu/cc | 2 |
37 | ka/m | 5 |
38 | kcal/oz | 2 |
39 | kg/m2and | 1 |
40 | kgm/2 | 1 |
41 | kv/min | 1 |
42 | mcg/min | 2 |
43 | mcg/strain | 1 |
44 | mg/day-placebo | 5 |
45 | mg/kg+placebo | 1 |
46 | mg/kg/6h | 1 |
47 | mgs/dl | 1 |
48 | mg® | 3 |
49 | mhz-1 | 1 |
50 | min | 22,795 |
51 | min-fa30 | 7 |
52 | min-views | 1 |
53 | min.day-1 | 7 |
54 | min.the | 2 |
55 | min/daily | 1 |
56 | min/hour | 4 |
57 | min/session | 33 |
58 | min/time | 2 |
59 | min/view | 1 |
60 | miti-coded | 1 |
61 | mixed-locations | 1 |
62 | mj/microbeam | 5 |
63 | ml.kg-1.h-1 | 3 |
64 | ml/kg-1 | 16 |
65 | ml/kg/bw-1 | 1 |
66 | monomethylation | 2 |
67 | mv-hz | 2 |
68 | nmol.l-1 | 2 |
69 | nmol.minute | 1 |
70 | non-can | 1 |
71 | non-neurosyphilitic | 1 |
72 | non-testers | 1 |
73 | non-transmitting | 1 |
74 | not-standardized | 1 |
75 | one-hour-sessions | 2 |
76 | packs-year | 2 |
77 | patients-group | 2 |
78 | patients/48 | 1 |
79 | persons/group | 1 |
80 | pg/h | 2 |
81 | pg/paw | 1 |
82 | pj/k | 1 |
83 | pmol/min | 14 |
84 | psgt | 1 |
85 | s/tooth | 1 |
86 | sapes | 1 |
87 | sec/day | 1 |
88 | segment-5 | 1 |
89 | squattings | 1 |
90 | stress-susceptible | 1 |
91 | symptomatic-lvef | 1 |
92 | thirst-minute | 1 |
93 | u/dl | 1 |
94 | u/kg/week | 2 |
95 | ui/h | 1 |
96 | vrm | 3 |
97 | w.d | 3 |
98 | wbcs/hpf | 5 |
99 | weeks+estramustine | 1 |
100 | £g/l | 1 |
101 | °c/open | 1 |
102 | µl/h | 2 |
103 | μg/glycopyrronium | 1 |
104 | μg/injection | 1 |
105 | μg/strain | 3 |
106 | μmoll | 2 |
1 | doctoral- | 1 |
2 | 000+/-1000 | 1 |
3 | min-fa30 | 7 |
4 | g·d-1 | 2 |
5 | ml/kg-1 | 16 |
6 | ml.kg-1.h-1 | 3 |
7 | nmol.l-1 | 2 |
8 | ml/kg/bw-1 | 1 |
9 | min.day-1 | 7 |
10 | mhz-1 | 1 |
11 | kgm/2 | 1 |
12 | 844.33 | 1 |
13 | segment-5 | 1 |
14 | alpha-hydroxy-5 | 2 |
15 | 998±2655 | 1 |
16 | alpha,6 | 3 |
17 | clones/977 | 2 |
18 | patients/48 | 1 |
19 | c.c | 5 |
20 | iu/cc | 2 |
21 | non-neurosyphilitic | 1 |
22 | w.d | 3 |
23 | 80mg/d | 1 |
24 | cigarettes/d | 8 |
25 | miti-coded | 1 |
26 | not-standardized | 1 |
27 | cavh-hd | 1 |
28 | kg/m2and | 1 |
29 | degrees/second | 3 |
30 | min.the | 2 |
31 | stress-susceptible | 1 |
32 | min/time | 2 |
33 | weeks+estramustine | 1 |
34 | alpha-dihydroxypregn-4-en-3-one | 2 |
35 | alpha-pregnanedione | 1 |
36 | alpha-dihydrotestosterone | 6 |
37 | g-glucose | 1 |
38 | birds/replicate | 3 |
39 | thirst-minute | 1 |
40 | nmol.minute | 1 |
41 | drops/minute | 1 |
42 | symptomatic-lvef | 1 |
43 | wbcs/hpf | 5 |
44 | 1dneg | 2 |
45 | h-heating | 1 |
46 | non-transmitting | 1 |
47 | pg/h | 2 |
48 | ui/h | 1 |
49 | µl/h | 2 |
50 | cycles/h | 2 |
51 | mg/kg/6h | 1 |
52 | s/tooth | 1 |
53 | pj/k | 1 |
54 | u/kg/week | 2 |
55 | fish/tank | 1 |
56 | £g/l | 1 |
57 | mgs/dl | 1 |
58 | u/dl | 1 |
59 | g/hl | 4 |
60 | dbhl | 5 |
61 | μmoll | 2 |
62 | ka/m | 5 |
63 | mj/microbeam | 5 |
64 | vrm | 3 |
65 | μg/glycopyrronium | 1 |
66 | non-can | 1 |
67 | broilers/pen | 2 |
68 | °c/open | 1 |
69 | mcg/strain | 1 |
70 | μg/strain | 3 |
71 | min | 22,795 |
72 | mcg/min | 2 |
73 | pmol/min | 14 |
74 | inflations/min | 1 |
75 | kv/min | 1 |
76 | min/session | 33 |
77 | monomethylation | 2 |
78 | carbonation/calcination | 1 |
79 | μg/injection | 1 |
80 | cm·h2o | 4 |
81 | mg/kg+placebo | 1 |
82 | mg/day-placebo | 5 |
83 | cmh₂o | 41 |
84 | patients-group | 2 |
85 | persons/group | 1 |
86 | packs-year | 2 |
87 | cfu/liter | 3 |
88 | min/hour | 4 |
89 | sapes | 1 |
90 | squattings | 1 |
91 | bufogenins | 1 |
92 | one-hour-sessions | 2 |
93 | mixed-locations | 1 |
94 | non-testers | 1 |
95 | min-views | 1 |
96 | psgt | 1 |
97 | carcasses/treatment | 1 |
98 | calves/treatment | 3 |
99 | pg/paw | 1 |
100 | min/view | 1 |
101 | sec/day | 1 |
102 | min/daily | 1 |
103 | mv-hz | 2 |
104 | kcal/oz | 2 |
105 | mg® | 3 |
106 | dyn/cm² | 5 |